Quince Therapeutics, Inc. Earnings Per Share Diluted

Quick Answer

Quince Therapeutics, Inc. reported Earnings Per Share Diluted of $1.31 (loss) per share for the year ending 2024.

  • Quince Therapeutics, Inc. showed a decrease of -56.0% in Earnings Per Share Diluted from 2023 to 2024.
  • This data is from Quince Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 24, 2025.
  • XBRL data for this metric is available from 2021 to 2024 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 4 years of available data (2021 to 2024), Quince Therapeutics, Inc.'s Earnings Per Share Diluted has grown by 56.8%.
  • Historical annual values: Fiscal year 2024: $1.31 (loss) per share | Fiscal year 2023: $0.84 (loss) per share | Fiscal year 2022: $1.54 (loss) per share | Fiscal year 2021: $3.03 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: